The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rucaparib vs docetaxel (DTX) or second-generation androgen pathway inhibitor (ARPI) therapy for metastatic castration-resistant prostate cancer (mCRPC): TRITON3 final overall survival (OS) and safety.
 
Alan Bryce
Honoraria - Astellas Pharma; Bayer; Bayer; Janssen; Janssen Oncology; Lantheus Medical Imaging; Lilly; MOMA Therapeutics; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Tolmar; Verity Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Clovis Oncology (Inst); Pfizer; Pfizer (Inst); Phosplatin Therapeutics (Inst)
 
Raymond McDermott
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Speakers' Bureau - MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen-Cilag; Pfizer; Roche
 
Josep Piulats
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Clovis Oncology; IDEAYA Biosciences; Immunocore; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche/Genentech; VCN Biosciences
Research Funding - AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Immunocore; Incyte; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Pfizer/EMD Serono
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Janssen Oncology; Pfizer; Roche
 
M. Reaume
Honoraria - Astellas Pharma; Astellas Pharma; AstraZeneca; Bayer; Bristol Myers Squibb; EMD serono; Ipsen; Merck; Novartis; Pfizer
Research Funding - AstraZeneca
 
Peter Ostler
No Relationships to Disclose
 
Joel Gingerich
Research Funding - Clovis Oncology (Inst)
 
Elias Pintus
Consulting or Advisory Role - Janssen; Johnson & Johnson/Janssen; MSD; Typharm
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
(OPTIONAL) Uncompensated Relationships - Bayer (Inst)
 
Srikala Sridhar
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)
 
Richard Bambury
Employment - Portable Medical Technology
Leadership - Portable Medical Technology
Stock and Other Ownership Interests - Portable Medical Technology
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
Travel, Accommodations, Expenses - Bayer
 
Urban Emmenegger
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Pfizer
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Knight Therapeutics; Merck; Pfizer
Research Funding - Astellas Pharma; Bayer; Janssen
 
Henriette Lindberg
Travel, Accommodations, Expenses - MSD; Novartis
 
David Morris
Stock and Other Ownership Interests - UROGPO
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Clovis Oncology; Decipher Biosciences; Dendreon; Janssen Oncology; Lantheus Medical Imaging; Merck Serono; Myovant Sciences; Myriad Genetics; Pfizer/EMD Serono; Urogen pharma; UROGPO
Speakers' Bureau - Astellas Medivation; AstraZeneca; Clovis Oncology; Janssen; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca/Merck (Inst); Bayer (Inst); Clovis Oncology (Inst); Dendreon (Inst); Exelixis (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer/Astellas (Inst); Urogen pharma (Inst)
 
Franco Nole
No Relationships to Disclose
 
John Staffurth
Honoraria - Johnson & Johnson
Consulting or Advisory Role - Amgen; Novartis
 
Wassim Abida
Honoraria - Aptitude Health; Clinical Education Alliance; Medscape; OncLive/MJH Life Sciences; Pfizer; Roche; theMedNet; touchIME
Consulting or Advisory Role - AstraZeneca/MedImmune; Clovis Oncology; Daiichi Sankyo; Endeavor BioMedicines; Janssen; Laekna Therapeutics; MOMA Therapeutics; ORIC Pharmaceuticals; Pfizer
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Epizyme (Inst); Merus (Inst); Nuvation Bio (Inst); ORIC Pharmaceuticals (Inst); TransThera Biosciences (Inst); Zenith Epigenetics (Inst)
(OPTIONAL) Uncompensated Relationships - Nuvation Bio
 
Lisa Caunt
No Relationships to Disclose
 
Darrin Despain
Employment - Pharmaand
 
Charles Ryan
Honoraria - Bayer; Janssen Oncology; Pfizer
Consulting or Advisory Role - ORIC Pharmaceuticals
 
Karim Fizazi
Honoraria - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Novartis (Inst)
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Janssen Oncology (Inst); MSD (Inst); Novartis (Inst); Orion; Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Janssen; MSD; Pfizer
 
Simon Chowdhury
Stock and Other Ownership Interests - Telix Pharmaceuticals
Honoraria - Novartis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Huma; Janssen-Cilag; Novartis; Pfizer; Remedy Bio; Telix Pharmaceuticals
Speakers' Bureau - Janssen-Cilag; Pfizer